Skip to content

A Randomized control trial, Double-blind, Placebo-controlled, Cross-over, single center Clinical trials on the hangover relief effects of ActiveNrich BOOST™

A Randomized control trial, Double-blind, Placebo-controlled, Cross-over, single center Clinical trials on the hangover relief effects of ActiveNrich BOOST™

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0009428
Enrollment
32
Registered
2024-05-13
Start date
2024-01-20
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Human clinical trials are double-blind, randomized, placebo control and cross-over design. Only candidates who voluntarily agreed to participate in the human application test are

Sponsors

CJ CheilJedang
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. A person who agrees to participate in this study and voluntarily signs a written consent form 2. Adult men and women aged 19 to 50 3. Body mass index (BMI) of 18.5 to 25 kg/m2 4. a person who has had a hangover after drinking 5. If you drink 1 to 2 bottles of soju 6. Adults in the normal range of blood tests and vital signs

Exclusion criteria

Exclusion criteria: 1. Experiencing excessive drinking and alcohol consumption within 7 days of screening visit 2. If you have alcohol use disorder or alcoholism 3. If you have participated in the human body application test within the last month 4. Dietary supplements and medications that may affect alcohol metabolism 5. Upon screening, the systolic blood pressure = 160 mmHg or = 100 mmHg, or diastolic blood pressure = 95 mmHg or = 60 mmHg, after a break of at least five minutes 6. People taking drugs, such as aspirin, drugs that are at risk of gastrointestinal bleeding, nonsteroidal drugs, and painkillers 7. Alcoholic metabolic disorders, diabetes, hypertension, cholelithiasis, pancreatitis, gout, active tuberculosis, gastrointestinal bleeding or surgery or kidney, liver disease (hepatitis B carriers, if alcoholic liver disease, etc.), heart, lung, gastrointestinal or neurological disorders 8. Pregnant women and nursing mothers 9. a person who usually rarely consumes alcohol or abstains from drinking less than once a month 10. A person who has never experienced a hangover due to his strong tolerance for alcohol 11. Any person deemed inappropriate by the researcher to participate in this examination 12. A smoker

Design outcomes

Primary

MeasureTime frame
AHS(Acute Hangover Scale)

Secondary

MeasureTime frame
AHSS(Alcohol Hangover Severity Scale);Blood alcohol concentration;Blood acetaldehyde concentration;ALT, AST, GGT

Countries

Korea, Republic of

Contacts

Public ContactChamin Baek

Global Medical Research Center

chamin38@gmail.com+82-2-517-0877

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026